Skip to main content
SUMOylation as a therapeutic target in inflammatory bowel diseases and sepsis

SUMOylation as a therapeutic target in inflammatory bowel diseases and sepsis

Unmet Need Inflammatory Bowel Disease (IBD) affects between 2.4 – 3.1 million people in the USA alone, with significant risks of complications such as sepsis. Chronic inflammation from IBD results in severe intestinal tissue damage,…

Read More

Novel factor VIIa chimeras for safer hemostasis

Novel factor VIIa chimeras for safer hemostasis

Unmet Need Chronic wounds impact 6.5 million patients in the US, leading to complications such as infections, hemorrhage, gangrene, and amputations. The resulting health burden costs the US healthcare system an estimated $25 billion annually…

Read More

A method of determining resistance of a blood cancer to PI3K inhibitors as well as treating blood cancers

A method of determining resistance of a blood cancer to PI3K inhibitors as well as treating blood cancers

Unmet Need Lymphomas are highly diverse and among the most common cancers in the US; approximately 1 in 50 Americans will be diagnosed with a lymphoma in their lifetime. Standard therapy for lymphomas generally includes…

Read More

G protein-coupled receptor kinase 2 and beta arrestins as therapeutic targets and diagnostic tools for hemoglobinopathies

G protein-coupled receptor kinase 2 and beta arrestins as therapeutic targets and diagnostic tools for hemoglobinopathies

Value Proposition Sickle cell disease affects millions of people throughout the world. Patients with sickle cell disease often experience episodes of acute pain that are caused by vaso-occlusive crisis. It is the leading cause of…

Read More

Aptamers to VMF

Aptamers to VMF

Focused aptamer libraries are constructed in accordance with a proteome (i.e., complex mixture of native biomolecules). The libraries may be screened to identify one or more candidate aptamers with desired biological activities other than specific…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us